The Role of the Joint Procurement Agreement during the COVID-19 Pandemic: Assessing Its Usefulness and Discussing Its Potential to Support a European Health Union
Emma McEvoy and Prof. Delia Ferri are delighted to announce that their article, “The Role of the Joint Procurement Agreement during the COVID-19 Pandemic: Assessing Its Usefulness and Discussing Its Potential to Support a European Health Union” has been published in the European Journal of Risk Regulation.
It explores the use of the European Joint Procurement Agreement (JPA) to organise the procurement of vaccines and medications in preparation for pandemics. The paper aims to understand the current use of the JPA in response to the Covid-19 pandemic. The importance and originality of this study are that it addresses an instrument, the JPA, which has been largely overlooked by legal scholars, and it explores how the provisions for the joint procurement of medical countermeasures as included in Article 5 of Decision 1082/2013/EU on serious cross-border threats to health could be extended to support the joint procurement of innovative health technologies and the development of a European Health Union.
Read the full paper at: https://doi.org/10.1017/err.2020.91